Didier Samuel
Didier Samuel
AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, F-94800, France ; Univ Paris-Sud, UMR-S 785, Villejuif, F-94800
pbr.aphp.fr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
International network of cancer genome projects
International Cancer Genome Consortium
Nature 464 (7291), 993, 2010
18162010
Liver transplantation in European patients with the hepatitis B surface antigen
D Samuel, R Muller, G Alexander, L Fassati, B Ducot, JP Benhamou, ...
New England Journal of Medicine 329 (25), 1842-1847, 1993
11641993
Statements from the Taormina expert meeting on occult hepatitis B virus infection
G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ...
Journal of hepatology 49 (4), 652-657, 2008
10022008
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
SK Sarin, A Kumar, JA Almeida, YK Chawla, ST Fan, H Garg, HJ de Silva, ...
Hepatology international 3 (1), 269-282, 2009
9562009
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
S Paramsothy, MA Kamm, NO Kaakoush, AJ Walsh, J van den Bogaerde, ...
The Lancet 389 (10075), 1218-1228, 2017
7152017
Early liver transplantation for severe alcoholic hepatitis
P Mathurin, C Moreno, D Samuel, J Dumortier, J Salleron, F Durand, ...
New England Journal of Medicine 365 (19), 1790-1800, 2011
7002011
EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version)
R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ...
Journal of Hepatology 39 (SUPPL. 1), 2003
678*2003
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
S Champiat, O Lambotte, E Barreau, R Belkhir, A Berdelou, F Carbonnel, ...
Annals of Oncology 27 (4), 559-574, 2016
6672016
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection
European FK506 Multicentre Liver Study Group
The Lancet 344 (8920), 423-428, 1994
6521994
EASL clinical practice guidelines: liver transplantation
P Burra, A Burroughs, I Graziadei, J Pirenne, JC Valdecasas, P Muiesan, ...
Journal of hepatology 64 (2), 433-485, 2016
618*2016
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre–and post–liver transplantation patients
ER Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ...
Hepatology 38 (6), 1419-1427, 2003
5722003
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
R Jalan, F Saliba, M Pavesi, A Amoros, R Moreau, P Ginès, E Levesque, ...
Journal of hepatology 61 (5), 1038-1047, 2014
5682014
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study
R Moreau, F Durand, T Poynard, C Duhamel, JP Cervoni, P Ichaï, ...
Gastroenterology 122 (4), 923-930, 2002
5592002
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)–NCT01514890
C Hézode, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, ...
Journal of hepatology 59 (3), 434-441, 2013
5212013
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014
SK Sarin, CK Kedarisetty, Z Abbas, D Amarapurkar, C Bihari, AC Chan, ...
Hepatology international 8 (4), 453-471, 2014
5192014
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
R Adam, D Azoulay, D Castaing, R Eshkenazy, G Pascal, K Hashizume, ...
Annals of surgery 238 (4), 508, 2003
4722003
Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
D Samuel, H Bismuth, A Bismuth, JL Arulnaden, D Mathieu, M Reynes, ...
The Lancet 337 (8745), 813-815, 1991
4491991
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma …
V Vilgrain, H Pereira, E Assenat, B Guiu, AD Ilonca, GP Pageaux, A Sibert, ...
The Lancet Oncology 18 (12), 1624-1636, 2017
4372017
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 …
M Manns, D Samuel, EJ Gane, D Mutimer, G McCaughan, M Buti, ...
The Lancet Infectious Diseases 16 (6), 685-697, 2016
4302016
Clinical course of acute‐on‐chronic liver failure syndrome and effects on prognosis
T Gustot, J Fernandez, E Garcia, F Morando, P Caraceni, C Alessandria, ...
Hepatology 62 (1), 243-252, 2015
4272015
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20